Co-Diagnostics (CODX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Co-Diagnostics (CODX) is Strong Underperform.

The composite score behind that read is -0.60, weighing +0.00 of bullish evidence against -0.60 bearish.

Co-Diagnostics last closed at $1.10, +1.85% on the session.

Against the IVW growth benchmark the position is +0.93% over the forecast window.

The read is built from 12 underlying insights — 0 bullish and 12 bearish.

Agreement across those insights is 100%.

16 graded predictions for CODX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Co-Diagnostics in the 5th percentile on return on equity, where 100 is best.

Co-Diagnostics is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $6.75M.

StockMap tracks Co-Diagnostics as the 130th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Co-Diagnostics ranks 132nd of 133 in the group, against a group median of -0.21.